Factors influencing the choice of bone metastases treatment
23 Jul 2010
Factors influencing the choice of bone metastases treatment
The launch of Sarah Cannon Research UK and research developments at ASCO 2010
Ovarian cancer research
Systemic therapy - what lies ahead?
MicroRNA as a treatment for chronic myelogenous leukaemia
Developments in the treatment of acute myeloid leukaemia (AML)
Phase III clinical trials at ASCO 2010
Drug developments presented at ASCO 2010
Advances in the treatment of melanoma
Advances in melanoma treatment
PARP inhibitors
Biotherapy Development Association